A novel antineuronal antibody in stiff-man syndrome

Robert B. Darnell, Jonathan Victor, Michael Rubin, Paul Clouston, Fred Plum

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Two-thirds of stiff-man syndrome (SMS) patients harbor an autoantibody specific for a 64-kD species of glutamic acid decarboxylase (GAD), the rate-limiting enzyme in GABA synthesis. We assayed SMS antisera from two patients with SMS for the presence of anti-GAD antibodies using Western blot, immunohistochemical, and enzymatic analyses. Both SMS antisera recognized an 80-kD antigen present in human and rat neuronal extracts, and failed to recognize the 64-kD GAD species. Immunohistochemistry demonstrated neuronal binding identical to that reported with anti-GAD antibodies. Both sera depleted GAD activity from brain extracts. Our analysis indicates that these SMS antisera differ from previously reported SMS antisera by recognizing a novel 80-kD antigen, and suggests that they contain antibodies directed against either a species of GAD different in size from the 64-kD enzyme, or a protein that co-immunoprecipitates with GAD.

Original languageEnglish
Pages (from-to)114-120
Number of pages7
JournalNeurology
Volume43
Issue number1
StatePublished - Jan 1993
Externally publishedYes

Fingerprint

Dive into the research topics of 'A novel antineuronal antibody in stiff-man syndrome'. Together they form a unique fingerprint.

Cite this